Banque Cantonale Vaudoise
- SEC CIK
- 0001793755
- Latest filing
- Jul 31, 2026
LH holding history
Labcorp Holdings Inc. in every 13F filed by Banque Cantonale Vaudoise, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LH overviewAll 13F holders of LHFull Q2 2026 holdings
- Shares (Q2 2026)
- 829
- Value
- $232.0K
- % of portfolio
- <0.1%
- Quarters held
- 18
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 829 | $232.0K | <0.1% | +439+112.6% | Added | Holders |
| Q1 2026 | 390 | $104.0K | <0.1% | +390 | New | Holders |
| Q4 2025 | 0 | $0 | 0.0% | −5,847−100.0% | Sold out | Holders |
| Q3 2025 | 5,847 | $1.68M | 0.1% | −183−3.0% | Reduced | Holders |
| Q2 2025 | 6,030 | $1.58M | 0.1% | +6,030 | New | Holders |
| Q4 2024 | – | – | – | – | Not filed | Holders |
| Q3 2024 | 2,058 | $461.0K | <0.1% | +2,058 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −1,262−100.0% | Sold out | Holders |
| Q1 2024 | 1,262 | $276.0K | <0.1% | −4,715−78.9% | Reduced | Holders |
| Q4 2023 | 5,977 | $1.36M | 0.1% | −661−10.0% | Reduced | Holders |
| Q3 2023 | 6,638 | $1.33M | 0.1% | +551+9.1% | Added | Holders |
| Q2 2023 | 6,087 | $1.47M | 0.1% | +3,200+110.8% | Added | Holders |
| Q1 2023 | 2,887 | $663.0K | <0.1% | −8,778−75.3% | Reduced | Holders |
| Q4 2022 | 11,665 | $2.75M | 0.1% | +7,785+200.6% | Added | Holders |
| Q3 2022 | 3,880 | $794.0K | <0.1% | −304−7.3% | Reduced | Holders |
| Q2 2022 | 4,184 | $980.0K | 0.1% | +597+16.6% | Added | Holders |
| Q1 2022 | 3,587 | $946.0K | <0.1% | −1,226−25.5% | Reduced | Holders |
| Q4 2021 | 4,813 | $1.51M | 0.1% | −202−4.0% | Reduced | Holders |
| Q3 2021 | 5,015 | $1.41M | 0.1% | −52−1.0% | Reduced | Holders |
| Q2 2021 | 5,067 | $1.40M | 0.1% | +511+11.2% | Added | Holders |
| Q1 2021 | 4,556 | $1.16M | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.